Bonnie Carney is of counsel at Leason Ellis, where her practice focuses on biotech patent prosecution, ranging from procurement of single U.S. patents to managing world-wide patents on such widely varied subject matter as orthopedic implants, pharmacological and gene therapy treatment for rare diseases, diagnostic and immunogenic compositions for detecting and treating viruses in food source fish, methods and composition for cancer immunotherapy, assay platforms, biomarkers and treatment for disease including hematological, psychological, neurodegenerative and ocular, bacteria delivery systems, and methods of producing differentiated cells. Her clients include major universities and hospitals in the greater New York area. Bonnie is involved in patent procurement at all levels, starting with meeting with inventors to discuss their work and the best way to pursue patent protection, to drafting initial and subsequent applications, to obtaining meaningful claims in many venues.
Bonnie became a patent attorney after graduating with a degree in Molecular Genetics and working in a lab at the University of Pennsylvania. She realized that while she enjoyed research in the biological sciences, her strengths lay elsewhere, thus she turned to patent law as a way to combine her interests with her abilities. Prior to joining Leason Ellis, Bonnie worked at Morgan and Finnegan, where she was involved in some of the earliest biotech patent litigations, and later at Darby and Darby, where she gained further experience in litigation as well as opinions and patent prosecution. Bonnie received her law degree, with Honors, from the George Washington University and her Bachelor of Science from the University of Rochester.